January 8, 2018
Calgene Corp buys Impact Biomedicines for $2,3 billion
Celgene Corporation and Impact Biomedicines have agreed for Celgene to acquire Impact Biomedicines, which is developing fedratinib for myelofibrosis and…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Impact Biomedicines